
The European Medicine Agency has begun to release to the public data on clinical trial via their own website. The …

Gilead Sciences has announced positive results from three Phase II studies upon their drug GS-4997, otherwise known as selonsertib. The …

The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …

Celgene International, part of Celgene Corporation, has released the results from a Phase Ib trial showing improvement in patients suffering …

Alnylam Pharmaceuticals’ shares lost close to half of their value as it was forced to end a trial of its …
Woodley Equipment Company Limited is pleased to announce Joanne Beckwith has joined Woodley’s Clinical Trials Division as Logistics Facilitator based at …

Originally published in the September edition of Pharmafocus, Matt Fellows investigates how cloud computing may just be the answer the …

The US Food and Drug Administration has permanently banned a clinical trial co-ordinator who was found to have falsified patient …

Regulators in Europe have initiated a safety review of Gilead Sciences’ (Nasdaq: GILD) blood cancer drug Zydelig (idelalisib) following reports …

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …
The ‘critical need’ to improve recruitment and retention in clinical trials is driving pharma to create a “structural change in …

AbbVie has announced it has begun six global Phase III trials of its once-daily, ribavirin-free investigational hepatitis C virus regimen, …

The number of clinical trials funded by pharma has risen significantly since 2006, while the number funded by the US …

GSK has entered the ‘smart drug’ industry by partnering with a health technology company to develop a sensor for use …